Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: A six-week placebo-controlled, double-blind, multicentre trial

Alimentary Pharmacology and Therapeutics

Volumn 18, Issue 11-12, 2003, Pages 1099-1105

  Holtmann, G ^a   Adam, B ^a   Haag, S ^a   Collet, W ^b   Grunewald E ^b   Windeck, T ^c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Winicker Norimed GmbH   (Germany)

^c Lichtwer Pharma AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYNARA SCOLYMUS EXTRACT; HEPARSL; PLACEBO;

ADNEXITIS; ADULT; AGED; ARTICHOKE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADOLESCENT; ADULT; AGED; CYNARA SCOLYMUS; DOUBLE-BLIND METHOD; DYSPEPSIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0346433968     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01767.x     Document Type: Article

References (23)

1. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyrén O, Stanghellini V. Functional dyspepsia, a classification with guidelines for diagnosis and management. Gastroenterol Int 1991; 4: 145-60.
2. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999; 45(Suppl. 2): II37-II42.
3. Talley NJ. Review article. Functional dyspepsia - Should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995; 9: 107-15.
4. Holtmann G, Talley NJ. Functional dyspepsia. Current treatment recommendations. Drugs 1993; 45: 918-30.
5. Talley NJ, McNeil D, Hayden A, Piper DW. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia. Gastroenterology 1986; 91: 149-56.
6. Talley NJ, Meineche-Schmidt V, Pare P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind randomised placebo-controlled trials. Aliment Pharmacol Ther 1998; 12: 1055-65.
7. Finney JS, Kinnersley N, Hughes M, O'Bryan-Tear CG, Lothian J. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol 1998; 26: 312-20.
8. Dobrilla G, Comberlato M, Steele A, Vallaperta P. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials. J Clin Gastroenterol 1989; 11: 169-77.
9. Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 2001; 96: 689-96.
10. Laine L, Schoenfeld P, Fennerty MB. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 134: 361-9.
11. Kirchhoff R, Beckers C, Kirchhoff G, Trinczek-Gärtner H, Petrowicz O, Reimann H. Increase in choleresis by means of artichoke extract. Results of a randomized placebo-controlled double blind study. Phytomedicine 1994; 1: 107-15.
12. Gebhardt R, Fausel M. Antioxidant and hepatoprotective effects of artichoke extracts and constituents in cultured rat hepatocytes. Toxicol Vitro 1997; 11: 669-72.
13. Gebhardt R. Inhibition of hepatic cholesterol biosynthesis by artichoke leaf extracts is mainly due to luteolin. Cell Biol Toxicol 1997; 13: 58.
14. Brown JE, Rice-Evans CA. Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro. Free Rad Res 1998; 29: 247-55.
15. Pérez-Garcia F, Adzet T, Canigueral S. Activity of artichoke leaf extract on reactive oxygen species in human leukocytes. Free Rad Res 2000; 33: 661-5.
16. Rechner AR, Pannala AS, Rice-Evans CA. Caffeic acid derivatives in artichoke extract are metabolised to phenolic acids in vivo. Free Rad Res 2001; 35: 195-202.
17. Fintelmann V. Langzeitanwendung eines Artischocken-Extraktes bei dyspeptischem Symptomkomplex. Ergebnisse einer Beobachtungsstudie. Naturamed 1998; 13: 17-26.
18. Marakis G, Walker AF, Middleton RW, Booth JCL, Wright J, Pike D. Artichoke leaf extract reduces mild dyspepsia in an open study. Phytomedicine 2002; 9: 664-99.
19. Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther 2001; 15: 207-16.
20. Talley NJ, Haque M, Wyeth JW, et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther 1999; 13: 225-35.
21. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJIII. Assessment of functional gastrointestinal disease: The bowel disease questionnaire. Mayo Clin Proc 1990; 65: 1456-79.
22. Holtmann G, Goebell H, Holtmann M, Talley NJ. Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci 1994; 39: 1090-8.
23. Van Zanten SJOV, Cleary C, Talley NJ, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996; 91: 660-73.